Hosaka Y, Tsukamoto T, Lieber M M
J Urol. 1986 Nov;136(5):1102-9. doi: 10.1016/s0022-5347(17)45232-3.
Use of the Hamburger-Salmon soft agar assay method for in vitro chemotherapy sensitivity testing of samples of renal cell carcinoma has been somewhat limited by a relatively low proliferation/evaluability rate for this tumor type (approximately 50%). The tritiated thymidine ([ 3H]-TdR) incorporation assay method of Tanigawa et al. (Cancer Res., 42: 2159, 1982) was compared to a standard optical colony counting assay technique. Fifty-seven different primary and five metastatic fresh samples of human renal cell carcinoma were studied. Evaluability rate by the [3H]-TdR assay was 90% (greater than or equal to 300 cpm control). In comparison, evaluability rate by optical colony counting was 43% for this group of tumors. [3H]-TdR incorporation increased with increasing tumor grade and increasing stage. Spindle cell tumors showed significantly higher cpm than other cell types. Twenty-three primary tumors were evaluable by both [3H]-TdR and colony counting methods. The correlation coefficient ("r") for regression lines for drug sensitivity data points (optical counting vs. [3H]-TdR) of these individual experiments ranged from 0.50 to 0.99 with a mean r +/- S.D. of 0.76 +/- 0.15. For all 260 paired drug response observations of 23 tumors exposed to different drugs, the correlation was very good with r = 0.71. Since the [3H]-TdR assay has an evaluability rate of approximately 90% for renal cell carcinoma, gives drug sensitivity information which correlates well with the colony counting endpoint and yields chemotherapy sensitivity information four days after sample accession, the [3H]-TdR assay may be a more useful method for study of human renal cell carcinoma in vitro chemotherapy sensitivity testing than standard colony counting techniques.
汉堡-鲑鱼软琼脂检测法用于肾细胞癌样本的体外化疗敏感性检测,因该肿瘤类型的增殖/可评估率相对较低(约50%)而受到一定限制。将谷川等人(《癌症研究》,42: 2159, 1982)的氚标记胸腺嘧啶核苷([³H]-TdR)掺入检测法与标准光学集落计数检测技术进行了比较。研究了57个不同的原发性和5个转移性人肾细胞癌新鲜样本。[³H]-TdR检测的可评估率为90%(大于或等于对照300 cpm)。相比之下,该组肿瘤的光学集落计数可评估率为43%。[³H]-TdR掺入量随肿瘤分级增加和分期增加而增加。梭形细胞瘤的cpm显著高于其他细胞类型。23个原发性肿瘤通过[³H]-TdR和集落计数法均可评估。这些个体实验中药物敏感性数据点(光学计数与[³H]-TdR)的回归线相关系数(“r”)范围为0.50至0.99,平均r±标准差为0.76±0.15。对于暴露于不同药物的23个肿瘤的所有260对药物反应观察结果,相关性非常好,r = 0.71。由于[³H]-TdR检测法对肾细胞癌的可评估率约为90%,能提供与集落计数终点相关性良好的药物敏感性信息,且在样本加入后四天即可得出化疗敏感性信息,因此[³H]-TdR检测法在研究人肾细胞癌体外化疗敏感性检测方面可能比标准集落计数技术更有用。